Descriptive Study of the Incidence and Outcome of PAS in Two Large Referral Hospitals in Egypt

Descriptive Study of the Incidence and Outcome of PAS in Two Large Referral Hospitals in Egypt , Kasr Alainy Hospital , Cairo University , and Banisuef Specialized Hospital in Last 6 Years

placenta accreta spectrum incidence and outcome

Study Overview

• Status: Active, not recruiting
• Conditions: Placenta Accreta

Detailed Description

placenta accreta spectrum ( PAS ) one of the most serious condition in obstetrics nowadays so the investigators measure the incidence by this study

• Study Type: Observational
• Enrollment (Anticipated): 10000

Contacts and Locations

Study Locations

• Egypt
  • Cairo, Egypt, 002
    • Kasr Alainy , Cairo University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 16 years to 43 years (Adult)
• Accepts Healthy Volunteers: N/A
• Genders Eligible for Study: Female

• Sampling Method: Non-Probability Sample

Study Population

pregnant woman above 28 weeks

Description

Inclusion Criteria:

• gestational age above 28 weeks

Exclusion Criteria:

• age less than 18

Study Plan

How is the study designed?

Design Details

• Observational Models: Other
• Time Perspectives: Retrospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
number of diagnosed pregnant women with placenta accreta spectrum	pregnant women with gestitional age above 18 week , with confirmed diagnosis with PAS with U/S	in last 6 years

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
incidence of hystrectomy	hystrectomy VS conservative management	in last 6 years

Collaborators and Investigators

• Sponsor: Cairo University
• Investigators: Principal Investigator: rihab hagag, resident, Kasr Alainy

Study record dates

Study Major Dates

• Study Start (Actual): July 30, 2022
• Primary Completion (Actual): November 10, 2022
• Study Completion (Anticipated): March 30, 2023

Study Registration Dates

• First Submitted: November 13, 2022
• First Submitted That Met QC Criteria: November 24, 2022
• First Posted (Actual): December 5, 2022

Study Record Updates

• Last Update Posted (Actual): December 5, 2022
• Last Update Submitted That Met QC Criteria: November 24, 2022
• Last Verified: November 1, 2022

More Information

Terms related to this study

• Keywords: PAS
• Additional Relevant MeSH Terms: Pregnancy Complications; Obstetric Labor Complications; Placenta Diseases; Placenta Accreta
• Other Study ID Numbers: MS-26-2022

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No
• IPD Plan Description: incidence of PAS

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No